Research AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failureBy Healthcare Propulsion StaffAugust 17, 20260 AstraZeneca reported positive results from two non-small cell lung cancer trials for Enhertu and an Orpathys-Tagrisso combination, although the dual…
